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Dendrimers are highly branched and star-shaped polymers with nanometer-scale dimensions.  The 
nanostructured macromolecules are known for their defined structures, versatility in drug delivery, and high 
functional properties similar to biomoleclules.   
 
We developed a new way to synthesize glucan dendrimer like glycogen by using branching enzyme (EC 
2.4.1.18) and glucan phosphorylase (EC 2.4.1.1) by using glucose-1-phosphate as a substrate.  This way 
enables us to produce glucan dendrimers with strictly controlled molecular size and branching structure.  In this 
context, we developed specific glycosylation technology to substitute glucose residues at non-reducing ends 
with galactose, mannose, glucosamine, glucuronic acid, or N-acetylglucosamine residues.  Glucose dendrimers 
having glucosamine and/or glucuronic acid residues are successfully used for conjugation of other functional 
molecules.  The nano-particle conjugated glucan dendrimers with peptide antigen and nucleotide adjuvant is a 
potential platform for vaccine. 
 
We investigated the glucan dendrimers function as a drug carrier.  The uptake of several glucose dendrimers 
into antigen-presenting cells (APCs), such as dendritic cell and macrophage, were examined.   Glucose 
dendrimers were incorporated into APCs, and introducing various sugar moieties into glucan dendrimers 
enhance the uptake them by APCs.  When glucan dendrimer-peptide conjugates were added to the cultured 
APCs, the peptides were effectively presented on the surface of APCs.  FITC-labeled glucan dendrimers 
injected subcutaneously in mice accumulated into inguinal lymph nodes, which play important role to introduce 
acquired immune response 
